The HOOK3 Knockout A-549 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human A-549 lung adenocarcinoma cell line, providing a stable loss-of-function model for the HOOK3 gene. Targeting HOOK3, this heterogeneous pool of disrupted cells allows for rigorous investigation of dynein/dynactin-mediated intracellular transport without the confounding effects of clonal selection. Researchers can reliably study HOOK3-dependent pathways in a polyclonal background.
The A-549 cell line, isolated from a 58-year-old male with lung adenocarcinoma, serves as a model for type II alveolar epithelial cells and retains key malignant features such as dysregulated proliferation and migration. Widely employed in non-small cell lung cancer research, these cells are used to study oncogenic pathways and drug responses. Their epithelial origin and robust growth facilitate analyses of lysosomal positioning and autophagy relevant to tumor progression.
HOOK3 is a cargo adaptor linking lysosomes and endosomes to the dynein motor complex via interactions with DYNC1H1 and the dynactin subunit DCTN1 (p150Glued). It cooperates with adaptors HOOK1 and AKTIP. AKT phosphorylation of HOOK3 enhances its dynein binding, a crucial step for retrograde transport and perinuclear lysosomal clustering. HOOK3 disruption impairs endosomal maturation, autophagosome transport, and lysosomal biogenesis, leading to peripheral dispersion of lysosomes and defective autophagy, which are critical for cellular homeostasis.
In A-549 lung adenocarcinoma cells, HOOK3-mediated lysosomal positioning supports invasive migration and autophagic survival mechanisms. The knockout model allows dissection of how disrupted retrograde transport affects cancer cell behavior. Given the association of HOOK3 with acute myeloid leukemia through HOOK3-KMT2A fusion proteins, as well as emerging roles in breast and prostate cancers, this model contributes to understanding oncogenic organelle trafficking. AKT-dependent regulation further highlights its utility in studying growth factor signaling crosstalk with organelle trafficking, particularly in metastasis and drug resistance contexts.
Applications include immunofluorescence microscopy for lysosomal distribution, live-cell imaging of retrograde transport dynamics, and co-immunoprecipitation to probe HOOK3-dynein complex integrity. Western blotting effectively validates HOOK3 ablation and monitors AKT substrate phosphorylation, while Transwell migration and MTT assays quantify functional outcomes. This model is ideally suited for drug screening campaigns targeting the HOOK3-dynein interaction or AKT-mediated lysosomal positioning. For further technical details, please contact Ascent Research.
